Synergistic Activity of Oxaliplatin and 5-Fluorouracil in Patients With Metastatic Colorectal Cancer With Progressive Disease While on or After 5-Fluorouracil-Reference-Cited by-同舟云学术

Synergistic Activity of Oxaliplatin and 5-Fluorouracil in Patients With Metastatic Colorectal Cancer With Progressive Disease While on or After 5-Fluorouracil

Published:1998-06 Issue:3 Volume:21 Page:279-283
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

deBraud F.,Munzone E.,Nolè F.,De Pas T.,Biffi R.,Brienza S.,Aapro M. S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference14 articles.

1. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

2. Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

3. Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-04

2. FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial;Therapeutic Advances in Medical Oncology;2022-01

3. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota;Frontiers in Immunology;2020-12-14

4. Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis;International Journal of Stem Cells;2019-07-30

5. Currently available first-line drug therapies for treating pancreatic cancer;Expert Opinion on Pharmacotherapy;2018-10-16